Antimicrobial Synergy of a Ribonuclease and a Peptide Secreted by Human Cells

ACS Infect Dis. 2020 Nov 13;6(11):3083-3088. doi: 10.1021/acsinfecdis.0c00594. Epub 2020 Oct 15.

Abstract

LL-37 is a secretory peptide that has antimicrobial activity. Ribonuclease 1 (RNase 1) is a secretory enzyme that is not cytotoxic. We find that human LL-37 and human RNase 1 can act synergistically to kill Gram-negative bacterial cells. In the presence of nontoxic concentrations of LL-37, RNase 1 is toxic to Escherichia coli cells at picomolar levels. Using wild-type RNase 1 and an inactive variant labeled with a fluorophore, we observe the adherence of RNase 1 to E. coli cells and its cellular entry in the presence of LL-37. These data suggest a natural means of modulating the human microbiome via the cooperation of an endogenous peptide (37 residues) and small enzyme (128 residues).

Keywords: antimicrobial peptide; cathelicidin; microbiome; ribonuclease 1; synergism.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Bacterial Agents
  • Anti-Infective Agents*
  • Antimicrobial Cationic Peptides* / pharmacology
  • Escherichia coli / genetics
  • Humans
  • Ribonucleases

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antimicrobial Cationic Peptides
  • Ribonucleases